The Role of RNA-Binding Proteins in Hematological Malignancies

The Role of RNA-Binding Proteins in Hematological Malignancies

Hematological malignancies comprise a plethora of different neoplasms, such as leukemia, lymphoma, and myeloma, plus a myriad of dysplasia, such as myelodysplastic syndromes or anemias. Despite all the advances in patient care and the development of new therapies, some of these malignancies remain i...

Full description

Bibliographic Details
Main Authors:	Pedro Aguilar-Garrido, Álvaro Otero-Sobrino, Miguel Ángel Navarro-Aguadero, María Velasco-Estévez, Miguel Gallardo
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	International Journal of Molecular Sciences
Subjects:	RNA-binding proteins leukemia lymphoma myeloma dysplasia
Online Access:	https://www.mdpi.com/1422-0067/23/17/9552

Similar Items

The Role of Tumor-Associated Macrophages in Hematologic Malignancies
by: Emanuele Cencini, et al.
Published: (2021-07-01)

Radiotheranostic Agents in Hematological Malignancies
by: Jo Caers, et al.
Published: (2022-07-01)

Role and Mechanisms of Tumor-Associated Macrophages in Hematological Malignancies
by: Yutong Xie, et al.
Published: (2022-07-01)

Deubiquitinases in hematological malignancies
by: Hu Lei, et al.
Published: (2021-08-01)

Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
by: Yi Zhang, et al.
Published: (2023-01-01)

Semaphorins and Their Receptors in Hematological Malignancies
by: Li Wei, et al.
Published: (2019-05-01)

Stem cell transplantation for hematologic malignancies /
by: Soiffer, Robert J.
Published: (2004)

Extracellular Vesicles in Hematological Malignancies: From Biomarkers to Therapeutic Tools
by: Jihane Khalife, et al.
Published: (2020-12-01)

Advancements on the Multifaceted Roles of Sphingolipids in Hematological Malignancies
by: Yasharah Raza, et al.
Published: (2022-10-01)

Critical Role of Aquaporins in Cancer: Focus on Hematological Malignancies
by: Alessandro Allegra, et al.
Published: (2022-08-01)

Bispecific Antibodies in Hematological Malignancies: A Scoping Review
by: Mohamed H. Omer, et al.
Published: (2023-09-01)

Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges
by: Giovanni Riva, et al.
Published: (2021-09-01)

The impact of NETosis on hematological malignancies as a promising therapeutic target
by: Duygu Aydemir, et al.
Published: (2024-03-01)

Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies
by: Paulina Biniecka, et al.
Published: (2023-02-01)

Chromosome Territories in Hematological Malignancies
by: Matheus Fabiao de Lima, et al.
Published: (2022-04-01)

The Pattern of Hematological Malignancies at Al-Gamhouria Teaching Hospital, Aden, Yemen, from 2008 to 2010
by: Gamal Abdul Hamid
Published: (2012-12-01)

TIGIT: A promising target to overcome the barrier of immunotherapy in hematological malignancies
by: Shenhe Jin, et al.
Published: (2022-12-01)

Dietary Acrylamide Intake and the Risk of Hematological Malignancies: The Japan Public Health Center-Based Prospective Study
by: Ling Zha, et al.
Published: (2021-02-01)

Hypogammaglobulinemia and Poor Performance Status are Predisposing Factors for Vancomycin-Resistant Enterococcus Colonization in Patients with Hematological Malignancies
by: Elif Gülsüm Ümit, et al.
Published: (2017-03-01)

From the (Epi)Genome to Metabolism and Vice Versa; Examples from Hematologic Malignancy
by: Panagiota Karagianni, et al.
Published: (2021-06-01)

Editorial: New emerging functions of transcription factors and RNA-binding proteins in the development of hematological malignancies
by: Tarik Möröy, et al.
Published: (2023-08-01)

Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview
by: Alessandro Barbato, et al.
Published: (2020-12-01)

Microbiota and Hematological Diseases
by: Guido D'Angelo
Published: (2022-07-01)

Metformin - its anti-cancer effects in hematologic malignancies
by: Monika Podhorecka
Published: (2021-02-01)

P2X7 Receptor in Hematological Malignancies
by: Elena De Marchi, et al.
Published: (2021-03-01)

COVID-19 in Patients With Hematologic Malignancies: A Single Center Retrospective Study
by: Xuejun Alice Wang, et al.
Published: (2021-10-01)

ROLE OF POLYMORPHISMS OF TOLL-LIKE RECEPTORS SIGNALING PATHWAY GENES IN THE DEVELOPMENT OF HEMATOLOGICAL MALIGNANCIES
by: E. L. Nazarova, et al.
Published: (2017-09-01)

Role of the gut microbiota in hematologic cancer
by: Patricia Guevara-Ramírez, et al.
Published: (2023-08-01)

Clinical application of CAR-T cells in treatment of hematologic malignancies
by: ZHANG Xi, et al.
Published: (2019-12-01)

Radioprotective Agents and Enhancers Factors. Preventive and Therapeutic Strategies for Oxidative Induced Radiotherapy Damages in Hematological Malignancies
by: Andrea Gaetano Allegra, et al.
Published: (2020-11-01)

Editorial: Case reports in hematological malignancies: 2022
by: Ahmad Antar, et al.
Published: (2023-08-01)

γδ T cells in immunotherapies for B-cell malignancies
by: Léa Rimailho, et al.
Published: (2023-06-01)

Advances in malignant hematology /
by: Saba, Hussain I. 536043, et al.
Published: (2011)

Management of Hematologic Malignancies in the Era of COVID-19 Pandemic: Pathogenetic Mechanisms, Impact of Obesity, Perspectives, and Challenges
by: Dimitrios Tsilingiris, et al.
Published: (2022-05-01)

Editorial: Epidemiological trends in hematological malignancies
by: Marcos de Lima, et al.
Published: (2023-02-01)

New Insights into YES-Associated Protein Signaling Pathways in Hematological Malignancies: Diagnostic and Therapeutic Challenges
by: Alessandro Allegra, et al.
Published: (2021-04-01)

Diagnostic and Therapeutic Potential of Extracellular Vesicles in B-Cell Malignancies
by: Ernesto Gargiulo, et al.
Published: (2020-09-01)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
by: Bruno Fattizzo, et al.
Published: (2022-05-01)

CD229 (Ly9) a Novel Biomarker for B-Cell Malignancies and Multiple Myeloma
by: Giovanna Roncador, et al.
Published: (2022-04-01)

A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017
by: Mohammad Keykhaei, et al.
Published: (2021-02-01)